Cancer Channel
Related Channels

Bexxar Radioimmunotherapy

Certain adults with non-Hodgkin's lymphoma may be able to slow down the progression of their cancer by receiving Bexxar® (tositumomab). This product is approved for use in people whose cancer has returned, or who have not adequately responded to other treatments.
As a type of radioimmunotherapy, Bexxar is linked to a radioactive element (Iodine I-131). The Bexxar-Iodine I-131 compound attaches to healthy cells and certain cancer cells, marking the cells to be destroyed by the immune system. Also, because Bexxar contain a radioactive element, it emits radiation that helps destroy both the cell the medicine is attached to and surrounding cancer cells.
(Click Bexxar for more details on this topic. This full-length article explains how the drug works, potential side effects, and why Bexxar is not suitable for some people.)
5 Easy Tips to Manage Visitors During Cancer Treatment
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.